Skip to content

Viscocanalostomy combined with nearly 360-degree suture trabeculotomy and primary trabeculectomy for medically uncontrolled chronic angle-closure glaucoma: a multi-center randomized controlled trial.

Viscocanalostomy combined with nearly 360-degree suture trabeculotomy and primary trabeculectomy for medically uncontrolled chronic angle-closure glaucoma: a multi-center randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121921
Enrollment
Unknown
Registered
2026-04-07
Start date
2023-12-08
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medically uncontrolled chronic angle-closure glaucoma

Interventions

Group 1 (Visco+360Trab):Viscocanalostomy combined with nearly 360-degree suture trabeculotomy
Group 2 (Primary Trab):Trabeculectomy

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 to 80 years old; 2. Primary chronic angle-closure glaucoma; 3. Severe glaucomatous visual field loss (According to Hodapp criteria); 4. Had lens extraction; 5. Uncontrolled glaucoma on maximally tolerated medical therapy; 6. Willingness to participate in a trial; 7. Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Primary angle-open glaucoma; 2. Secondary glaucoma; 3. Mild and moderate glaucomatous visual field loss (Hodapp); 4. Phakic eye; 5. Medically controlled glaucoma; 6. Inability to undergo surgery; 7. females who are pregnant or nursing.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure (IOP);Visual field;Best-corrected visual acuity;Optical coherence tomography (OCT);Medications during follow-up;Any expected or unexpected complications and adverse effects during treatment or at any time during follow-up. ;

Secondary

MeasureTime frame
Patient reported health status;Patient reported visual status;

Countries

China

Contacts

Public ContactSun Hong

The First Affiliated Hospital with Nanjing Medical University

hollysh8@sina.com+86 133 9076 6677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026